Global alliance against chronic respiratory diseases

被引:162
作者
Bousquet, J.
Dahl, R.
Khaltaev, N.
机构
[1] WHO, CH-1211 Geneva 27, Switzerland
[2] CHU Montpellier, Hop Arnaude de Villeneuve, Montpellier, France
[3] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
关键词
asthma; chronic obstructive pulmonary disease; chronic respiratory diseases; World Health Organization;
D O I
10.1111/j.1398-9995.2007.01307.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Hundreds of millions of people of all ages suffer from chronic respiratory diseases which include asthma and respiratory allergies, chronic obstructive pulmonary disease, occupational lung diseases and pulmonary hypertension. More than 500 million patients live in developing countries or in deprived populations. Chronic respiratory diseases are increasing in prevalence. Although the cost of in action is clear and unacceptable, chronic respiratory diseases and their risk factors receive in sufficient attention from the health care community, government officials, media, patients and families. The Fifty-Third World Health Assembly recognized the enormous human suffering caused by chronic diseases and requested the World Health Organization (WHO) Director General to give priority to the prevention and control of chronic diseases, with special emphasis on developing countries. This led to the formation of the WHO Global Alliance against Chronic Respiratory Diseases (GARD). GARD is a voluntary alliance of organizations, institutions and agencies working towards a common vision to improve global lung health according to local needs. GARD is developed in a stepwise approach using the following three planning steps: estimate population need and advocate action; formulate and adopt policy; and identify policy implementation steps.
引用
收藏
页码:216 / 223
页数:8
相关论文
共 44 条
[1]   Characterization of high-altitude pulmonary hypertension in the Kyrgyz: Association with angiotensin-converting enzyme genotype [J].
Aldashev, AA ;
Sarybaev, AS ;
Sydykov, AS ;
Kalmyrzaev, BB ;
Kim, EV ;
Mamanova, LB ;
Maripov, R ;
Kojonazarov, BK ;
Mirrakhimov, MM ;
Wilkins, MR ;
Morrell, NW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (10) :1396-1402
[2]  
Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P665
[3]   American Thoracic Society Statement: Occupational contribution to the burden of airway disease [J].
Balmes, J ;
Becklake, M ;
Blanc, P ;
Henneberger, P ;
Kreiss, K ;
Mapp, C ;
Milton, D ;
Schwartz, D ;
Toren, K ;
Viegi, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (05) :787-797
[4]   Pulmonary hypertension in schistosomiasis mansoni [J].
Barbosa, MM ;
Lamounier, JA ;
Oliveira, EC ;
Souza, MV ;
Marques, DS ;
Silva, AA ;
Lambertucci, JR .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1996, 90 (06) :663-665
[5]   Epidemiological characterization of the intermittent and persistent types of allergic rhinitis [J].
Bauchau, V ;
Durham, SR .
ALLERGY, 2005, 60 (03) :350-353
[6]   Prevalence and rate of diagnosis of allergic rhinitis in Europe [J].
Bauchau, V ;
Durham, SR .
EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (05) :758-764
[7]   Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema:: ISAAC [J].
Beasley, R ;
Keil, U ;
von Mutius, E ;
Pearce, N ;
Aït-Khaled, N ;
Anabwani, G ;
Anderson, HR ;
Asher, MI ;
Björkstéin, B ;
Burr, ML ;
Clayton, TO ;
Crane, J ;
Ellwood, P ;
Lai, CKW ;
Mallol, J ;
Martinez, FD ;
Mitchell, EA ;
Montefort, S ;
Robertson, CF ;
Shah, JR ;
Sibbald, B ;
Stewart, AW ;
Strachan, DP ;
Weiland, SK ;
Williams, HC .
LANCET, 1998, 351 (9111) :1225-1232
[8]  
Billo NE, 2004, INT J TUBERC LUNG D, V8, P391
[9]  
Bruce N, 2000, B WORLD HEALTH ORGAN, V78, P1078
[10]   Use of asthma guidelines by primary care providers to reduce hospitalizations and emergency department visits in poor minority, urban children [J].
Cloutier, MM ;
Hall, CB ;
Wakefield, DB ;
Bailit, H .
JOURNAL OF PEDIATRICS, 2005, 146 (05) :591-597